Authors: Brynne, L McNay, JL Schaefer, HG Swedberg, K Wiltse, CG Karlsson, MO

Citation: L. Brynne et al., Pharmacodynamic models for the cardiovascular effects of moxonidine in patients with congestive heart failure, BR J CL PH, 51(1), 2001, pp. 35-43

Authors: Brynne, L Paalzow, LK Karlsson, MO

Citation: L. Brynne et al., Consequence of exercise on the cardiovascular effects of I-propranolol in spontaneously hypertensive rats, J PHARM EXP, 294(3), 2000, pp. 1201-1208

Authors: Gardmark, M Brynne, L Hammarlund-Udenaes, M Karlsson, MO

Citation: M. Gardmark et al., Interchangeability and predictive performance of empirical tolerance models (vol 36, pg 145, 1999), CLIN PHARMA, 36(5), 1999, pp. 328-328

Authors: Gardmark, M Brynne, L Hammarlund-Udenaes, M Karlsson, MO

Citation: M. Gardmark et al., Interchangeability and predictive performance of empirical tolerance models, CLIN PHARMA, 36(2), 1999, pp. 145-167

Authors: Brynne, L Paalzow, LK Karlsson, MO

Citation: L. Brynne et al., Mechanism-based modeling of rebound tachycardia after chronic I-propranolol infusion in spontaneous hypertensive rats, J PHARM EXP, 290(2), 1999, pp. 664-671